High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer.
Kotz
K W
KW
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Schilder
R J
RJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D018394:CA-125 Antigen / Q000032:analysis; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007263:Infusions, Parenteral; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D012086:Reoperation
D018394:CA-125 Antigen; D003520:Cyclophosphamide; D016190:Carboplatin; D002945:Cisplatin